Notification
No new Notification messages
Enviro Infra Engineers IPO is Open!
Apply for the Enviro Infra Engineers IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
artemis med service ltd stock

ARTEMIS MED SERVICE LTD Share Price

312.05 -8.15 (-2.54%)
Nov 22 2024 03:30 PM Healthcare NSE: ARTEMISMED

ARTEMIS MED SERVICE LTD Share Price Update

As of the latest trading session, ARTEMIS MED SERVICE LTD share price is currently at 312.05, which is down by -8.15 from its previous closing. Today, the stock has fluctuated between 307.10 and 335.00. Over the past year, ARTEMIS MED SERVICE LTD has achieved a return of 87.41 %. In the last month alone, the return has been 15.63 %. Read More...

ARTEMIS MED SERVICE LTD Performance

Day Range

Low307.10 High335.00
312.05

52 Week Range

Low 141.30 High 304.70
312.05

ARTEMIS MED SERVICE LTD Share Price

16913

542919

ARTEMISMED

img img img img
No Data Available

Open Price

326.00

Prev. Close

320.20

Volume (Shares)

1371794.00

Total traded value

4280.68

Upper Circuit

384.20

Lower Circuit

256.20

Note: The current prices & values are delayed, Login to your account for live updates.

ARTEMIS MED SERVICE LTD Fundamentals


(Standalone)

Market Cap (Cr) 4239.52
PE Ratio (TTM) 66.26
Book Value / Share 52.93
Beta 0.74
ROE 13.60%
EPS (TTM) 4.72
Dividend Yield 0.14%
Net Profit Qtr (Cr) 22.56

ARTEMIS MED SERVICE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 234.67
Operating Expense 211.09
Net Profit 22.56
Net Profit Margin (%) 9.61
Earnings Per Share (EPS) 1.44
EBITDA 49.28
Effective Tax Rate (%) 27.41
Particulars JUN 2024 (Values in Cr)
Revenue 216.89
Operating Expense 199.14
Net Profit 16.92
Net Profit Margin (%) 7.80
Earnings Per Share (EPS) 1.16
EBITDA 40.06
Effective Tax Rate (%) 23.57
Particulars MAR 2024 (Values in Cr)
Revenue 216.87
Operating Expense 199.30
Net Profit 13.92
Net Profit Margin (%) 6.41
Earnings Per Share (EPS) 1.02
EBITDA 37.98
Effective Tax Rate (%) 28.39
Particulars DEC 2023 (Values in Cr)
Revenue 210.26
Operating Expense 195.70
Net Profit 11.51
Net Profit Margin (%) 5.47
Earnings Per Share (EPS) 0.85
EBITDA 33.41
Effective Tax Rate (%) 29.19
Particulars SEP 2023 (Values in Cr)
Revenue 216.91
Operating Expense 200.45
Net Profit 13.77
Net Profit Margin (%) 6.34
Earnings Per Share (EPS) 1.01
EBITDA 35.80
Effective Tax Rate (%) 27.29
Particulars MAR 2024 (Values in Cr)
Revenue 845.23
Operating Expense 784.47
Net Profit 49.15
Net Profit Margin (%) 5.81
Earnings Per Share (EPS) 3.62
EBITDA 135.66
Effective Tax Rate (%) 27.76
Particulars MAR 2023 (Values in Cr)
Revenue 714.33
Operating Expense 668.60
Net Profit 39.69
Net Profit Margin (%) 5.55
Earnings Per Share (EPS) 2.98
EBITDA 100.92
Effective Tax Rate (%) 24.93
Particulars MAR 2022 (Values in Cr)
Revenue 544.78
Operating Expense 509.86
Net Profit 32.58
Net Profit Margin (%) 5.98
Earnings Per Share (EPS) 2.46
EBITDA 71.06
Effective Tax Rate (%) 16.05
Particulars MAR 2021 (Values in Cr)
Revenue 402.06
Operating Expense 399.94
Net Profit 7.09
Net Profit Margin (%) 1.76
Earnings Per Share (EPS) 0.54
EBITDA 41.83
Effective Tax Rate (%) 20.42
Particulars MAR 2020 (Values in Cr)
Revenue 563.09
Operating Expense 535.70
Net Profit 20.43
Net Profit Margin (%) 3.62
Earnings Per Share (EPS) 15.43
EBITDA 66.81
Effective Tax Rate (%) 36.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.00
ROE % 13.72
ROCE % 14.87
Total Debt to Total Equity 0.85
EBITDA Margin 15.94
Particulars MAR 2023 (Values in Cr)
Book Value / Share 25.03
ROE % 12.10
ROCE % 12.41
Total Debt to Total Equity 0.78
EBITDA Margin 13.74
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.10
ROE % 11.50
ROCE % 10.81
Total Debt to Total Equity 0.64
EBITDA Margin 12.86
Particulars MAR 2021 (Values in Cr)
Book Value / Share 191.73
ROE % 2.33
ROCE % 4.51
Total Debt to Total Equity 0.52
EBITDA Margin 9.54
Particulars MAR 2020 (Values in Cr)
Book Value / Share 186.78
ROE % 8.19
ROCE % 12.17
Total Debt to Total Equity 0.48
EBITDA Margin 11.69
Particulars MAR 2024 (Values in Cr)
Book Value / Share 28.24
ROE % 13.60
ROCE % 14.85
Total Debt to Total Equity 0.79
EBITDA Margin 16.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 25.28
ROE % 12.53
ROCE % 12.88
Total Debt to Total Equity 0.72
EBITDA Margin 14.13
Particulars MAR 2022 (Values in Cr)
Book Value / Share 22.26
ROE % 11.85
ROCE % 11.20
Total Debt to Total Equity 0.60
EBITDA Margin 13.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 192.81
ROE % 2.52
ROCE % 4.77
Total Debt to Total Equity 0.49
EBITDA Margin 9.65
Particulars MAR 2020 (Values in Cr)
Book Value / Share 187.41
ROE % 8.83
ROCE % 12.54
Total Debt to Total Equity 0.47
EBITDA Margin 11.86
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 61.34
Total Assets 971.51
Total Liabilities 971.51
Total Equity 454.68
Share Outstanding 135860500
Price to Book Ratio 6.01
Return on Assets (%) 5.05
Return on Capital (%) 6.94
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 50.94
Total Assets 904.95
Total Liabilities 904.95
Total Equity 407.68
Share Outstanding 134118750
Price to Book Ratio 2.69
Return on Assets (%) 4.26
Return on Capital (%) 5.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 27.69
Total Assets 709.66
Total Liabilities 709.66
Total Equity 361.26
Share Outstanding 132377000
Price to Book Ratio 2.06
Return on Assets (%) 4.48
Return on Capital (%) 5.84
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 31.11
Total Assets 600.08
Total Liabilities 600.08
Total Equity 321.74
Share Outstanding 13237700
Price to Book Ratio 1.15
Return on Assets (%) 1.08
Return on Capital (%) 1.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 15.65
Total Assets 586.44
Total Liabilities 586.44
Total Equity 313.71
Share Outstanding 13237700
Price to Book Ratio 0.74
Return on Assets (%) 3.37
Return on Capital (%) 5.07
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 57.93
Total Assets 948.03
Total Liabilities 948.03
Total Equity 451.63
Share Outstanding 135860500
Price to Book Ratio 6.01
Return on Assets (%) 5.18
Return on Capital (%) 7.12
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 48.32
Total Assets 881.83
Total Liabilities 881.83
Total Equity 406.42
Share Outstanding 134118750
Price to Book Ratio 2.69
Return on Assets (%) 4.50
Return on Capital (%) 6.3
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 27.11
Total Assets 697.40
Total Liabilities 697.40
Total Equity 361.61
Share Outstanding 132377000
Price to Book Ratio 2.06
Return on Assets (%) 4.67
Return on Capital (%) 6.1
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 28.84
Total Assets 588.95
Total Liabilities 588.95
Total Equity 321.62
Share Outstanding 13237700
Price to Book Ratio 1.15
Return on Assets (%) 1.20
Return on Capital (%) 1.61
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 15.23
Total Assets 581.16
Total Liabilities 581.16
Total Equity 314.06
Share Outstanding 13237700
Price to Book Ratio 0.74
Return on Assets (%) 3.51
Return on Capital (%) 5.3
Particulars MAR 2024 (Values in Cr)
Net Income 68.45
Cash from Operations 114.68
Cash from Investing -86.99
Cash from Financing -30.12
Net change in Cash -8.25
Free Cash Flow 187.23
Particulars MAR 2023 (Values in Cr)
Net Income 50.60
Cash from Operations 130.03
Cash from Investing -158.21
Cash from Financing 38.22
Net change in Cash 7.16
Free Cash Flow 276.50
Particulars MAR 2022 (Values in Cr)
Net Income 37.18
Cash from Operations 42.82
Cash from Investing -107.22
Cash from Financing 44.22
Net change in Cash -3.46
Free Cash Flow 151.73
Particulars MAR 2021 (Values in Cr)
Net Income 7.53
Cash from Operations 29.39
Cash from Investing -37.42
Cash from Financing 17.71
Net change in Cash 7.55
Free Cash Flow 63.89
Particulars MAR 2020 (Values in Cr)
Net Income 30.62
Cash from Operations 60.33
Cash from Investing -26.29
Cash from Financing -27.42
Net change in Cash 2.36
Free Cash Flow 86.33
Particulars MAR 2024 (Values in Cr)
Net Income 68.04
Cash from Operations 112.17
Cash from Investing -88.96
Cash from Financing -27.03
Net change in Cash -8.41
Free Cash Flow 183.97
Particulars MAR 2023 (Values in Cr)
Net Income 52.86
Cash from Operations 131.80
Cash from Investing -152.53
Cash from Financing 29.73
Net change in Cash 6.55
Free Cash Flow 267.67
Particulars MAR 2022 (Values in Cr)
Net Income 38.80
Cash from Operations 76.99
Cash from Investing -106.09
Cash from Financing 43.65
Net change in Cash -1.77
Free Cash Flow 183.53
Particulars MAR 2021 (Values in Cr)
Net Income 8.90
Cash from Operations 29.41
Cash from Investing -34.07
Cash from Financing 12.72
Net change in Cash 5.69
Free Cash Flow 57.68
Particulars MAR 2020 (Values in Cr)
Net Income 31.96
Cash from Operations 60.65
Cash from Investing -21.52
Cash from Financing -33.00
Net change in Cash 1.95
Free Cash Flow 80.22
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6932.35 84.25 13.30 99676.56 5286.00 / 7545.10
FORTIS MALAR HOSPITALS LIMITED 52.95 0.00 3.32 99.24 44.00 / 107.94
SHREE PACETRONIX LTD. 120.15 19.35 3.21 43.25 114.95 / 310.95
TRANSGENE BIOTEK LTD. 6.40 0.00 4.47 48.49 5.79 / 12.46
Company Name Price P/E P/B Market Cap 52 Week Low/High
APOLLO HOSPITALS ENTER. L 6932.35 88.76 12.16 99676.56 5286.00 / 7545.10
Surlux Diagnostic Ltd 1.40 0.84 0.13 0.49 0.00 / 0.00
CHENNAI MEENAKSHI MULTISPECIAL 39.39 0.00 -21.10 29.42 29.25 / 54.65
KOVAI MEDICAL CENTER & HOSPITA 5236.00 28.40 5.88 5728.18 3050.00 / 5770.00

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 299.40
  • 26 Days 284.50
  • 10 Days 292.00
  • 50 Days 282.50
  • 12 Days 290.20
  • 100 Days 259.80
  • 20 Days 285.80
  • 200 Days 192.20
311.37
PIVOT
First Resistance 332.83
Second Resistance 345.47
Third Resistance 366.93
First Support 298.73
Second Support 277.27
Third Support 264.63
RSI 65.96
MACD 5.64
Commodity Channel Index (CCI) 304.00
ADX 16.19
Williams % R -33.14

Over 1 Month

down

15.63

Over 3 Months

down

16.58

Over 6 Months

down

71.36

Over 1 Year

down

87.41

Over 3 Years

down

109.57

Over 5 Years

down

69.08

ARTEMIS MED SERVICE LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ARTEMIS MED SERVICE LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
31.4
Promoter Holdings
67.17
FII
0.21
DII
1.22
Promoter Shares(Pledge Percentage)
44.53
Name Category Shares Shares%
Constructive Finance Private Limited Shareholding of Promoter and Promoter Group 9.242579E7 67.17
Governor Of Kerala Public Shareholding 6749600.0 4.91
Devlina Chakravarty Public Shareholding 3532192.0 2.57
Kerala State Industrial Development Corporation Public Shareholding 3000000.0 2.18
Artemis Medicare Services Limited-unclaimed Suspense Account Public Shareholding 2352420.0 1.71
International Finance Corporation Public Shareholding 0.0 0.0
Onkar Kanwar Shareholding of Promoter and Promoter Group 5000.0 0.0

ARTEMIS MED SERVICE LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-07-14 0.45 Final 2023-07-14 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2021-09-23 10.0 1.0 2021-09-24

Learn More About Stocks

About ARTEMIS MED SERVICE LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ARTEMIS MED SERVICE LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Artemis Medicare Services Ltd?

Answer Field

The share price of Artemis Medicare Services Ltd for NSE is ₹ 312.05 and for BSE is ₹ 310.8.

What is the Market Cap of Artemis Medicare Services Ltd?

Answer Field

The market cap of Artemis Medicare Services Ltd for NSE is ₹ 42,39.52 Cr. and for BSE is ₹ 42,22.54 Cr. as of now.

What is the 52 Week High and Low of Artemis Medicare Services Ltd?

Answer Field

The 52 Week High and Low of Artemis Medicare Services Ltd for NSE is ₹ 335.00 and ₹ 141.30 and for BSE is ₹ 333.95 and ₹ 140.60.

How to Buy Artemis Medicare Services Ltd share?

Answer Field

You can trade in Artemis Medicare Services Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Artemis Medicare Services Ltd?

Answer Field

The 1 year returns on the stock has been 87.41%.

What is the Current Share Price of Artemis Medicare Services Ltd?

Answer Field

Artemis Medicare Services Ltd share price is for NSE ₹ 312.05 & for BSE ₹ 310.8 as on Nov 22 2024 03:30 PM.

What is the Market Cap of Artemis Medicare Services Ltd Share?

Answer Field

The market cap of Artemis Medicare Services Ltd for NSE ₹ 42,39.52 & for BSE ₹ 42,22.54 as on Nov 22 2024 03:30 PM.

What is the P/E Ratio of Artemis Medicare Services Ltd Share?

Answer Field

As on Nov 22 2024 03:30 PM the price-to-earnings (PE) ratio for Artemis Medicare Services Ltd share is 66.26.

What is the PB ratio of Artemis Medicare Services Ltd Share?

Answer Field

As on Nov 22 2024 03:30 PM, the price-to-book (PB) ratio for Artemis Medicare Services Ltd share is 52.93.

How to Buy Artemis Medicare Services Ltd Share?

Answer Field

You can trade in Artemis Medicare Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Artemis Medicare Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Artemis Medicare Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Artemis Medicare Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader